ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis.
Susan M CottonM BerkA WatsonS WoodK AllottC F BartholomeuszC C BortolasciK WalderB O'DonoghueO M DeanA ChanenG P AmmingerP D McGorryA BurnsideJ UrenA RatheeshS DoddPublished in: Trials (2019)
Australian New Zealand Clinical Trials Registry, ID: ACTRN12618000413224. Registered on 21 March 2018.